US2022162653A1PendingUtilityA1
Preparation of (R)-3-Hydroxybutyric Acid or Its Salts by One-Step Fermentation
Est. expiryApr 4, 2037(~10.7 yrs left)· nominal 20-yr term from priority
C12N 9/0006C12N 9/1029C12N 9/13C12N 1/205C12P 7/42C12N 1/20C12R 2001/15C07C 53/124
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The subject invention relates to a genetically modified microorganism comprising a (R)-3-hydroxybutyric acid pathway and being able of producing (R)-3-hydroxybutyric acid, and a method of preparing (R)-3-hydroxybutyric acid or a salt thereof using the genetically modified microorganism.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A genetically modified microorganism having (R)-3-hydroxybutyrate biosynthesis capability, comprising one or more exogenous nucleic acids encoding at least one (R)-3-hydroxybutyric acid pathway enzyme selected from succinyl-CoA transferase, acetoacetyl-CoA synthase, and 3-HB dehydrogenase.
2 . The genetically modified microorganism of claim 1 , wherein the genetically modified microorganism is able to produce (R)-3-hydroxybutyric acid in a pathway comprising the following steps:
(i) converting pyruvic acid and coenzyme A to acetyl-CoA, (ii) converting acetyl-CoA into acetoacetyl-CoA, (iii) converting acetoacetyl-CoA to acetoacetic acid, and (iv) converting acetoacetic acid to (R)-3-hydroxybutyric acid.
3 . The genetically modified microorganism of claim 1 , wherein the exogenous nucleic acid is codon-optimized gene for expression in the genetically modified microorganism.
4 . The genetically modified microorganism of claim 1 , wherein the pathway enzyme encoded by exogenous nucleic acids is succinyl-CoA transferase, acetoacetyl-CoA synthase, or 3-HB dehydrogenase.
5 . The genetically modified microorganism of claim 1 , wherein the pathway enzyme encoded by exogenous nucleic acids are succinyl-CoA transferase, acetoacetyl-CoA synthase and 3-HB dehydrogenase.
6 . The genetically modified microorganism of claim 1 , wherein the exogenous nucleic acid encoding succinyl-CoA transferase is at least 90% identical to the nucleotide sequence of SEQ ID NO:1.
7 . The genetically modified microorganism of claim 1 , wherein the exogenous nucleic acid encoding acetoacetyl-CoA synthase is at least 90% identical to the nucleotide sequence of SEQ ID NO:2.
8 . The genetically modified microorganism of claim 1 , wherein the exogenous nucleic acid encoding 3-HB dehydrogenase is at least 90% identical to the nucleotide sequence of SEQ ID NO:3.
9 . The genetically modified microorganism of claim 1 , wherein the microorganism is nonpathogenic microorganism selected from the group consisting of Corynebacterium glutamicum, Bacillus subtilis, Brevibacterium lactofermentum, Brevibacterium difficile, Brevibacterium flavum, and Brevibacterium breve.
10 . The genetically modified microorganism of claim 9 , wherein the microorganism is Corynebacterium glutamicum or Bacillus subtilis.
11 . The genetically modified microorganism of claim 9 , wherein the microorganism is Corynebacterium glutamicum.
12 . The genetically modified microorganism of claim 11 , wherein the Corynebacterium glutamicum is the the strain deposited at the China General Microbiological Culture Collection Center under the accession number CGMCC No. 13111.
13 . A method for producing (R)-3-hydroxybutyric acid, comprising using the genetically modified microorganism of claim 1 .
14 . The method of claim 13 , wherein the method is a one-step fermentation process comprising fermenting the genetically modified microorganism of claim 1 .
15 . A recombinant nucleic acid segment encoding succinyl-CoA transferase, acetoacetyl-CoA synthase, and 3-HB dehydrogenase.Join the waitlist — get patent alerts
Track US2022162653A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.